Marie Abate, Pharm.D.

Abate MA.  Drug Information Resources & Literature Retrieval, In Book 5, Pharmacotherapy Self-Assessment Program (PSAP) IV Science and Practice of Pharmacotherapy, American College of Clinical Pharmacy, 2002, pgs. 1-34

Abate MA. Drug Information Resources & Literature Retrieval - Answers to Self-Assessment Questions, In Answer Book, Pharmacotherapy Self-Assessment Program (PSAP), 4th edition, American College of Clinical Pharmacy, 2002, pgs. 1-6

Abate MA, Ponte CD. Diarrhea case study - Accentuation of Evacuation, (facilitators guide also prepared) In: Pharmacotherapy: A Patient-Focused Approach. 5th ed. Schwinghammer TL, Ed., Appleton & Lange: Connecticut, 2002, pgs. 113-115

Jacknowitz AI, Abate MA. Basic Bibliography - Gastrointestinal Disorders. Hosp Pharm 2002;37(4):433-434

Patrick S. Callery, Ph.D.

Schenck, F.J., Callery, P.S., Gannett, P.M., Daft, J., Lehotay, S.J. “How Dry is dry?  Removal of Water from Pesticide Extracts of Foods After Salting Out”, (2002) J AOAC International, 85:1177-1180.

Callery PS and Gannett PM. “Cancer and Cancer Chemotherapy”. In “Foye’s Principles of Medicinal Chemistry”, Fifth Edition, D.A. Williams and T.L. Lemke, editors, Lippincott Williams and Wilkins, Philadelphia, 2002.

Diane Casdorph, Pharm.D.

Slain D, Casdorph D, McIntire T. Assessment of an Antiretroviral Adherence Sensitivity Training Exercise in the Doctor of Pharmacy Curriculum. American Journal of Pharmaceutical Education Fall 2002;66:277‑280.

David Elliott, Pharm.D.

Eskins, B, Elliott D.P, “Reminyl (galantamine)”. New Drug Update (2002) 7 (2):1-4.

Peter M. Gannett, Ph.D.

Powell, J.H., and Gannett, P.M. “Mechanisms of Carcinogenicity of Aryl Hydrazines, Aryl Hydrazides, and Arenediazonium Ions.”  (2002) J. Environ. Pathol. Toxicol. Oncol.   21:1-32.

Gannett, P.M., Powell, J.H., Johnson, II, E.M., Darian, E., Dalal, N., Norton, M., Budil, D. “Solid Phase DNA Annealing Characterization by EPR Spectroscopy”(2002) Tetrahed. Lett.,43:1931-34.

Schenck, F.J., Callery, P.S., Gannett, P.M., Daft, J., Lehotay, S.J. “How Dry is dry?  Removal of Water from Pesticide Extracts of Foods After Salting Out”, (2002) J AOAC International, 85:1177-1180.

Gannett, P.M., Darian, E., Powell, J.H., Johnson, III, E.M., Mundoma, C., Greenbaum, N.L., Ramsey, C.M., Dalal, N.S., Budil, D.E. “Probing Triplex Formation by EPR Spectroscopy Using a Newly Synthesized Spin Label for Oligonucleotides”, (2002) Nucl. Acids Res. 30:5328-5337.

Callery PS and Gannett PM. “Cancer and Cancer Chemotherapy”. In “Foye’s Principles of Medicinal Chemistry”, Fifth Edition, D.A. Williams and T.L. Lemke, editors, Lippincott Williams and Wilkins, Philadelphia, 2002.

Robert K. Griffith, Ph.D.

Griffith RK, Tracy TS.  Antifungal Drugs. In “Foye’s Principles of Medicinal Chemistry”, Fifth Edition, D.A. Williams and T.L. Lemke, editors, Lippincott Williams and Wilkins, Philadelphia, 2002.

Griffith RK. Drugs Affecting Adrenergic Neurotransmission. In “Foye’s Principles of Medicinal Chemistry”, Fifth Edition, D.A. Williams and T.L. Lemke, editors, Lippincott Williams and Wilkins, Philadelphia, 2002.

Chittur, SV and Griffith, RK, Multisubstrate Analog Inhibitors of Glucosamine-6-phosphate Synthase from C albicans", Bioorganic and Medicinal Chemistry Letters, 2002, 12,2639-2642.

Robert Haining, Ph.D.

Yu, A., Kneller, B., Rettie, A.E., and Haining, R.L.  (2002) Expression, Purification, Biochemical Characterization and Comparative Function of Human Cytochrome P450 2D6.1, 2D6.2, 2D6.10 and 2D6.17 Allelic Isoforms  J.Pharm.Exp.Ther. 303:1291-1300.

Ramamoorthy, Y., Yu, A., Suh, N., Haining, R.L., Tyndale, R.F., and Sellers, E.M.  (2002) Reduced (+/-)-3,4-methylenedioxymethamphetamine ("Ecstasy") metabolism with cytochrome P450 2D6 inhibitors and pharmacogenetic variants in vitro.  Biochem. Pharmacol. 63:2111-9.

Tracy, T.S., Hutzler, J.M., Haining, R.L., Rettie, A.E., Hummel, M.A., and Dickmann, L.J.  (2002) Polymorphic variants (CYP2C9*3 and CYP2C9*5) and the F114L active site mutation of CYP2C9: effect on atypical kinetic metabolism profiles. Drug Metab.Dispos. 30: 385-90.

Suzuki, H., Kneller, B. M., Haining, R. L., Trager, W. F. and Rettie, A. E.  (2002) (+)-N-3-Benzyl Nirvanol and (-)-N-3-Benzyl-Phenobarbital: New Potent and Selective In Vitro Inhibitors of CYP2C19. Drug Metab.Dispos. 30: 235-9.

Arthur Jacknowitz, Pharm.D.

Jacknowitz AI. Comment: Hepatitis B Vaccine Safety – Letter to the editor – Annuals of Pharmacotherapy 36: 1649-1650 (October, 2002).

Jacknowitz AI, Danzig J. Pharmacist Initiatives in the Management of Hepatitis C – Pharmacy Times 68 (9): 74-84 (September, 2002).

Jacknowitz AI. Basic Bibliography-External Analgesics, Hospital Pharmacy – 37:884-885 (August, 2002).

Prabhu S, Jacknowitz AI, Stout PJ. “Evaluating the Dissolution Behavior of Zinc-Complexed Protein Suspensions By Computer Modeling and Simulation”. Drug Development and Industrial Pharmacy 28: 703-709 (June, 2002).

Jacknowitz AI, Abate MA.  Basic Bibliography-Gastrointestinal Diseases. Hospital Pharmacy 37: 433-434 (April, 2002).

Jacknowitz AI (Chairperson, Advisory Board), Carson DS, Nadler SF et. al. American Pharmaceutical Association New Product Bulletin on Thermacare ^TM  Therapeutic Heatwraps, pp 1-13 (February 2002).

Kristy Lucas, Pharm.D.

Lucas BD, Elhabyan AK, Lucas KH.  Rationale for Increasing the Starting Dose of Simvastatin.  Clinical Drug Investigation and Drugs in Research and Development 2002;22(9):639-40.

Nursing 2002 Drug Handbook, 22nd Edition.  Springhouse, Pa:  Springhouse Corp., 2002 Lucas KH, author of monograph and patient teaching aid:  Foradil

Nurse Practitioner's Drug Handbook, 4th Edition.  Springhouse, Pa:  Springhouse Corp., 2002 Lucas KH, author of monograph:  Foradil

Lucas KH.  Herbal Products:  Pearls, Perils, and Precautions for the Prescriber.  The Female Patient 2002;27(12):34‑38.

Joseph Ma, Ph.D.

Yang, H.M., Antonini, J.M., Barger, M.W., Buterworth, L., Roberts, J.R., Ma, J.K.H., Castranova, V., and Ma J.Y.C., “Diesel Exhaust particles suppress macrophage function and slow the pulmonary clearance of Listeria Monocytogenes in rats,” Environ Health Perspectives, 2001,109:515-521.

Castranova, V., Ma, J.Y.C., Yang, H.M., Antonini, J.M., Barger, M.W., Buterworth, L., Roberts, J.R., and Ma, J.K.H., “Effect of exposure to diesel exhaust particles on the susceptibility of the lung to infection,” Environ Health Perspectives, 2001, 109:609-612.

Al-Humadi, N.H.; Siegel, P.D.; Lewis, D.M.; Barger, M.W.; Ma, J.Y.C.; Weissman, D.N.; Ma, J.K.H. Alteration of Intracellular Cysteine and Glutathione Levels in Alveolar Macrophages and Lymphocytes by Diesel Exhaust Particles Exposure. Environ. Health Perspect. 2002, 110, 349-353.

Al-Humadi, N.H.; Siegel, P.D.; Lewis, D.M.; Barger, M.W.; Ma, J.Y.C.; Weissman,  D.N.; Ma, J.K.H. The Effect of Diesel Exhaust Particles (DEP) and Carbon Black (CB) on Thiol Changes in Pulmonary Ovalbumin Allergic Sensitized Brown Norway Rats. Exp. Lung Res. 2002, 28, 333-349.

Yang, X.D., Ma, J.Y.C., Barger, M.W., and Ma, J.K.H., “Transport and utilization of arginine and arginine-containing peptides in alveolar macrophages,” Pharmaceutical Research, 2002, 19, 825-831.

Yin, X.; Schafer, R.; Ma, J.Y.C.; Antonini, J.M.; Weissman, D.N.; Siegel, P.D.; Barger, M.W.; Roberts, J.R.; Ma, J.K.H. Alteration of Pulmonary Immunity to Listeria monocytogenes by Diesel Exhaust Particles (DEP) I. Effect of DEP on Early Pulmonary Responses.  Environ. Health Perspect. 2002, 110, 1105-1111.

Ma, J.Y.C. and Ma, J.K.H., “ The Dual Effects of Particulate and Organic Components of Diesel Exhaust Particles on Pulmonary Immune/inflammatory Responses and Metabolic Enzymes,”  J. Environ. Sci. & Health (Part C - Enviromental Carcinogenesis and Ecotoxicology Reviews), 2002, C20, 117-147.

Suresh Madhavan, MBA, Ph.D.

Momani, A., Madhavan, SS, Nau D.  "The Impact  of a Prior‑authorization Program for NSAIDs on Health Related Quality of Life of Patients." Annals of Pharmacotherapy. 2002; 36 (Nov): 1686‑91.

Amonkar MM, Madhavan SS. "Compliance Rates and Predictors of Cancer Screening Recommendations Among Appalachian Women." Journal of Health Care for the Poor and Underserved.  2002;  13(4): 443‑460

Thomas McIntire, MBA

McIntire TM, “PDAs An Emerging Tool in Pharmacy Education, Pharmacy Student, 2002; November/December, 9

Betsy Meredith, Pharm.D.

Meredith, B., Cupp, M.J., Tracy, T.S. Gamma‑Hydroxybutyric acid (GBL), Gamma‑Butyrolactone (GBL), and 1,4‑Butanediol (BD), In “Dietary Supplements: Toxicology and Clinical Pharmacology” Cupp, M.J., and Tracy, T.S., Eds., Humana Press: Totowa, N.J, 2002.

Meredith, B., Small, R., Wixted, A., Davis, R.  "Evaluation of Patient Knowledge Regarding Herbal Product Labeling in an Independent Community Pharmacy Setting." JAPhA. March/April 2002.

Paula Jo Meyer-Stout, Ph.D.

S. Prabhu, A. Jacknowitz, and PJ Meyer‑Stout,  "Evaluating Dissolution Behavior of Zinc‑Complexed Suspensions by Computer Modeling and Simulation", Drug Development and Industrial Pharmacy, 28(6), 703‑709 (2002).

William Petros, Pharm.D.

Bohjanen PR, Johnson MD, Szczech LA, Wray DW, Petros WP, Miller CR, Hicks CB.  Steady-state pharmacokinetics of lamivudine in HIV-infected patients with end-stage renal disease receiving chronic dialysis.  Antimicrob Agents Chemother> 2002;46:2387-2392.

Petros WP, Broadwater G, Berry D, Jones RB, Vredenburgh JJ, Gilbert CJ, Gibbs JP, Colvin OM, Peters WP.  Association of high-dose cyclophosphamide, cisplatin and carmustine pharmacokinetics with response, toxicity and dosing weight in patients with primary breast cancer.  Clin Cancer Res 2002;8:698-705.

Martell RE, Peterson B, Cohen HJ, Petros W, Rai KR, Larson R, Schiffer C, Elias L, Sheperd L, Hurwitz HI.  Analysis of age, estimated creatinine clearance and pretreatment hematologic parameters as predictors of fludarabine toxicity in patients treated for chronic lymphocytic leukemia: A CALGB (9011) coordinated Intergroup Study.  Cancer Chemother pharmacol 2002;50:37-45.

Rizvi NA, Marshall JL, Ness E, Hawkins MJ, Kessler C, Jacobs H, Brenckman W, Lee JS, Petros WP, Hong WK, Kurie J.  Initial clinical trial of oral TAC-101, a novel RAR-selective retinoid in patients with advanced cancer. JClin Oncol 2002;20:3522-3532

Dowlati A, Robertson K,Cooney M, Petros WP, Stratford M, Jesberger J, Rafie N, OvermoyerB, Makkar V, Stambler B, Taylor A, Waas J, Lewin J, McCrae KR, Remick SC.  A Phase I Pharmacokinetic and Translational Study of the Novel Vascular Targeting Agent Combretastatin A4 Phosphate (CA4P) on a Single-Dose Intravenous Schedule in Patients with Advanced Cancer.  Cancer Res 2002;62:3408-3416.

Rizzieri D, Bass AJ, Rosner GL, Gockerman JP, DeCastro CM, Petros WP, Adams DJ, Laughlin MJ, Davis P, Foster T, Jacobson R, Hurwitz H, Moore JO.  Phase I evaluation of continuous-infusion gemcitabine with mitoxantrone for relapsed or refractory acute leukemia. J Clin Oncol 2002;20:674-679.

Petros WP and Long GL.  Hematopoiesis.  In: DiPiro JT, Talbert RL, Yee GC, Matzke GR, Wells BG, Posey LM, eds.  Pharmacotherapy: A Pathophysiologic Approach, Appleton & Lange. Fifth Edition, 2002, 1717-1727.

Medan D, Wang L, Yang X, Dokka S, Castranova V, Rojanasakul Y. Induction of neutrophil apoptosis and secondary necrosis during endotoxin-induced pulmonary inflammation in mice. J Cell Physiol. 191(3):320-326, 2002.

Lu B, Wang L, Medan D, Toledo D, Huang C, Chen F, Shi X, Rojanasakul Y. Regulation of Fas (CD95)-induced apoptosis by nuclear factor-kappaB and tumor necrosis factor-alpha in macrophages. Am J Physiol Cell Physiol. 283(3):C831-C838, 2002.

Chen F, Bower J, Leonard S, Ding M, Lu Y, Rojanasakul Y, Kung H, Vallyathan V, Castranova V, Shi X. Protective roles of NF-kappaB for chromium (VI)-induced cytotoxicity is revealed by expression of IkappaB kinase-beta mutant. J Biol Chem. 277:3342-3349, 2002.

Wang L, Medan D, Mercer R, Shi X, Huang C, Castranova V, Ding M, Rojanasakul Y. Role of Neutrophil apoptosis in vanadium-induced pulmonary inflammation in mice. J Envir Pathol Toxicol Oncol. 21(4):343-350, 2002.

Tantishaiyakul V, Wiwattanawongsa K, Pinsuwan S, Kasiwong S, Phadoongsombut N, Kaewnopparat S, Kaewnopparat N, Rojanasakul Y. Characterization of mefenamic acid-guaiacol ester: Stability and transport across Caco-2 cell monolayers. Pharm Res. 19(7):1013-1018, 2002.

Wang L, Antonini JM, Rojanasakul Y, Castranova V, Scabilloni JF, Mercer RR. Potential role of apoptotic macrophages in pulmonary inflammation and fibrosis. J Cell Physiol. 194(2):215-224, 2002.

Douglas Slain, Pharm.D.

Slain D, Miller K, Khakoo RA,  Fisher MA, Wierman T,  Jozefczyk K. Infrequent Occurrence of Amphotericin B Lipid Complex (ABLC)‑Associated Nephrotoxicity in Various Clinical Settings at a University Hospital: A retrospective study. Clin Ther 2002; 24: 1636‑42.

Slain D, Casdorph D, McIntire T.  Assessment of an Antiretroviral Adherence Sensitivity Training Exercise in The Doctor of Pharmacy Curriculum. Am J Pharm Educ 2002: 66; 277‑80.

Mary Stamatakis, Pharm.D.

Stamatakis MK.  Strategies for treatment and prevention of acute renal failure.  J Pharm Prac 2002;14(5):392‑404.

Grazyna Szklarz, Ph.D.

Szklarz, G.D. and Paulsen, M.D. 2002. Molecular modeling of cytochrome P450 1A1: Enzyme-substrate interactions and substrate binding affinities. J. Biomol. Struct. Dyn. 20:155-162.

Liu, J., Ericksen, S.S., Besspiata, D., Fisher, C.W. and Szklarz, G.D. 2003. Characterization of substrate binding to cytochrome P450 1A1 using molecular modeling and kinetic analyses: case of residue 382. Drug Metab. Disp. 31:412-420.

Timothy Tracy, Ph.D.

Hutzler JM, Kolwankar D, Hummel MA, Tracy TS.  Effector structural requirements for activation of CYP2C9‑mediated metabolism. Drug Metab Dispos, 30:1194‑1200, 2002.

Hutzler JM, Tracy TS.  Atypical Kinetic Profiles in Drug Metabolism Reactions.  Drug Metab Dispos, 30:355‑362, 2002.

Tracy TS, Hutzler JM, Haining RL, Rettie AE, Hummel MA, Dickmann LJ.  Polymorphic variants (CYP2C9*3 and CYP2C9*5) and the F114L active site mutation of CYP2C9:  Effect on atypical kinetic metabolism profiles.  Drug Metab Dispos, 30:385‑390, 2002.

Griffith RK, Tracy TS.  Antifungal Drugs. In “Foye’s Principles of Medicinal Chemistry”, Fifth Edition, D.A. Williams and T.L. Lemke, editors, Lippincott Williams and Wilkins, Philadelphia, 2002.
 

***Note that the listing is by faculty member names, and some multi-authored publications are listed more than once.